
One AI Stock Rose. The Market Fell.Anthropic (ANT) opened at $111.50 on its first day of trading, 34% above its $83 IPO price. It closed at $97.17, up 17% from the offering. Almost everything else went the other way. The S&P 500 rose as much as 1.3% early, then fell 2.0% for its sixth straight loss. The Dow lost 2.2% and closed below 50,000. The Nasdaq also fell 2.2%. Every S&P 500 sector finished lower, and the VIX closed above 28. The S&P 500 had already erased its early gain before Anthropic's first trade, and the selling sped up after it. The buying stayed inside the new stock. The chipmakers and cloud companies tied to it fell with everything else. TQ Trade Implication Investors paid up for one AI stock and sold much of the rest. A new listing can draw heavy buying without lifting the stocks around it. That makes Anthropic a poor gauge of AI appetite, and the broad index a better one. If Anthropic holds its gain while the S&P 500 posts a seventh straight loss, money is moving into the new name instead of back into the sector.
The next 12 months could make or break your retirement. That's the warning from Dr. Mark Skousen, the economist who called Black Monday, the '95 tech boom and the 2009 bottom. And it has nothing to do with the crash everyone keeps predicting. He says something far stranger is underway... and most people will miss it completely. See his warning free, right here... while there's still time to act.
Crypto Traders Priced Anthropic's Open, Not Its CloseBefore the listing, crypto traders priced Anthropic above its IPO range. A Hyperliquid contract tracking one share, which gives holders no actual stock, traded at $96.61 early Wednesday, before the IPO priced. Just before the first Nasdaq trade, it was within 1% of the $111.50 open, Senpi data showed. The stock touched $115.10, fell as low as $92.72 and closed back near the contract's Wednesday level. The float is thin. The 980 million shares sold are about 7.4% of the shares outstanding, by our estimate from the filing. Staff and non-founder insiders can sell up to 10% of their locked shares from day one. After the close, MSCI said it will add the stock to its main indexes early, effective at the Nov. 30 close, according to reports. Amazon (AMZN) and Alphabet (GOOGL), both large Anthropic holders, fell 3.9% and 3.5%. The IPO put a public price on their stakes, and their own shares slid anyway. TQ Edge Setup The side market priced the open, and the stock then fell well below it. With so little of the company trading, small shifts in supply or demand move the price a lot. Scheduled insider sales and index buying can move the price more than any new view of the business. If the stock still trades below its first print when MSCI's addition takes effect, the index bid is already in the price.
AMD Took a Short Report on the Day Washington's Chip Rule Took EffectAMD (AMD) fell 7.7% after Hunterbrook Capital disclosed a short position, a day after gaining 5.3%. Its media affiliate alleged that a blacklisted Chinese server maker, IEIT Systems, kept getting newer AMD firmware. AMD denied any wrongdoing. The report landed as Commerce's rule on remote access to advanced chips took effect. It requires licenses for advanced-chip shipments to five countries, including Singapore and Malaysia. Existing deals get 90 days to secure a license. By Hunterbrook's count, AMD billed $4.28 billion to Singapore customers in fiscal 2025. Nvidia (NVDA) fell 3.3% to a 52-week low, its sixth straight decline. Hunterbrook profits if AMD falls, and its claims are unproven. Investors sold first. TQ Execution Bias The market charged AMD for a claim it denies and no regulator has acted on. Export rules now follow where chips are used. Sales into data-center hubs like Singapore are now the exposure that matters. That tilts against chipmakers that lean on those hubs until the first licenses arrive. If Commerce clears existing deals well inside the 90-day window, Thursday's selling priced a risk that never landed.
Why Did Trump Just Ban America's Most Powerful AI?It's not Nvidia. It's not OpenAI. It's not Google. It's a San Francisco AI lab whose technology is used by eight of the ten largest companies in America — and which Bloomberg calls the highest-revenue AI company on earth. Trump banned it from every federal agency and the Pentagon blacklisted it. The reason isn't what you think. Full details here.
Factory Activity Slowed. Factory Costs Jumped.The Philadelphia Fed's factory index fell to 6.3 in November from 20.9, far below forecasts. In the same survey, prices paid jumped to 58.2 from 43.2 and prices received rose to 47.0 from 40.1. Treasuries rallied as stocks fell. The 10-year yield slipped to 5.05% from 5.07%, its fourth straight decline. Money markets already treat a December hike as all but certain, and the debate is over size. The next big test is October's PCE inflation report on Nov. 25. TQ Edge Setup Manufacturers reported slower business and faster cost growth at once. Higher prices received show some of that cost is being passed on. That keeps hikes on the table even as yields fall. If October's PCE runs hot and long yields keep falling anyway, bond buyers are betting the slowdown beats the Fed.
- Walmart raised its outlook a second time. Walmart (WMT) beat forecasts with $188.8 billion of revenue and 65 cents of adjusted earnings a share. Its new full-year range of $2.84 to $2.89 a share only matches the $2.89 analysts expected at the top. U.S. comparable sales excluding fuel rose 2.9%, against 4.5% a year earlier. The stock fell 1%.
- Intuit sold Mailchimp for under a third of its price. Intuit (INTU) topped sales and profit forecasts. It agreed to sell Mailchimp to Bending Spoons, a private Italian buyer, for about $3.68 billion. Intuit paid $12 billion for it in 2021. It also trimmed its full-year sales outlook, and the shares fell about 10% after hours.
- Kalshi lost again on appeal. A divided Fourth Circuit panel ruled Tuesday that Kalshi cannot stop Maryland from enforcing state gambling law against its sports contracts. It is Kalshi's third loss in four federal appeals courts. New Jersey has asked the Supreme Court to settle the split.
Wall Street veteran goes ALL in on Bank of Elon
A 20-year Wall Street veteran – who worked at a $10 billion hedge fund – is putting ALL his money in Elon Musk's new bank. He says he can see the writing on the wall for traditional banks. And he's not the only one. See if you should join him here (not just for the 6% yield). This ad is sent on behalf of InvestorPlace Media at 1125 N. Charles Street, Baltimore, Maryland 21201. If you're not interested in this opportunity, please click here.
Thursday's AI Buying Had One AddressThursday's AI buying went to the one stock with a thin float. Chipmakers, cloud companies and the S&P 500 were sold, and AMD was marked down over China ties on the day a new export rule took effect. Anthropic's next sessions decide whether that money spreads. If it holds above Thursday's close while chip stocks keep falling, investors are swapping old AI holdings for the new one. If the S&P 500 snaps its losing streak while Anthropic slides toward $83, Thursday's buying was a one-day event.
AI Found the Target. AI Designed the Drug. Now It's in Phase III.For years, AI drug discovery had a problem. Plenty of models. Very few medicines. That's changing. One company says AI identified the biological target and then designed the molecule to hit it. In September, the first patient in its Phase III trial was dosed. It isn't alone. A second AI-engineered medicine is in Phase III, and Big Pharma is now paying for the technology. We profiled the 5 companies pushing AI into real drug development in a new FREE Special Report: AI Moves Into the Biotech Lab. We'll text it straight to your phone. Get the Free Report by Text → |
|